PainReform (PRFX)

• Market cap: $2.54M
• 1 day: -3.82%
• 5 days: 2.44%
• 1 month: -11.27%
• 3 months: -13.7%
• 6 months: -48.36%
• Year to date: -61.11%
• 1 year: -43.75%
• 5 years: -99.89%
• 10 years: -99.92%
• Sector: Healthcare
• Industry: Drug Manufacturers - Specialty & Generic

About: PainReform Ltd is a clinical-stage specialty pharmaceutical company. It is focused on the reformulation of established therapeutics. The company's product PRF-110 is based on the local anesthetic ropivacaine, targeting the post-operative pain relief market. PRF-110 is an oil-based, viscous, clear solution that is deposited directly into the surgical wound bed before closure to provide localized and extended post-operative analgesia.

Employees: 6